Reduced Drinking in Alcohol Dependence Treatment, What Is the Evidence?

German Guidelines on Screening, Diagnosis and Treatment of Alcohol Use Disorders

(2017) Karl Mann et al.   EUROPEAN ADDICTION RESEARCH

Weak evidence on nalmefene creates dilemmas for clinicians and poses questions for regulators and researchers

(2016) Niamh Fitzgerald et al.   ADDICTION

Harm reduction -a systematic review on effects of alcohol reduction on physical and mental symptoms

(2016) Katrin Charlet et al.   ADDICTION BIOLOGY

Alcohol Consumption and Inpatient Health Service Utilization in a Cohort of Patients With Alcohol Dependence After 20 Years of Follow-up

(2016) Laia Miquel et al.   ALCOHOL AND ALCOHOLISM

Clinical Validation of Reduced Alcohol Consumption After Treatment for Alcohol Dependence Using the World Health Organization Risk Drinking Levels

(2016) Katie Witkiewitz et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Nalmefene for the management of alcohol dependence: review on its pharmacology, mechanism of action and meta-analysis on its clinical efficacy

(2016) Karl Mann et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Balancing Risk and Benefit in Heavy Drinkers Treated With Topiramate

(2016) Richard Feinn et al.   JOURNAL OF CLINICAL PSYCHIATRY

Do “Moderate” Drinkers Have Reduced Mortality Risk? A Systematic Review and Meta-Analysis of Alcohol Consumption and All-Cause Mortality

(2016) Tim Stockwell et al.   Journal of Studies on Alcohol and Drugs

Marketing Status and Perceived Efficacy of Drugs for Supporting Abstinence and Reducing Alcohol Intake in Alcohol Use Disorders: A Survey among European Federation of Addiction Societies in Europe

(2016) Jørgen G. Bramness et al.   EUROPEAN ADDICTION RESEARCH

Treatment Seeking for Alcohol Use Disorders: Treatment Gap or Adequate Self-Selection?

(2016) Marlous Tuithof et al.   EUROPEAN ADDICTION RESEARCH

A Trial-Based Predictive Microsimulation Assessing the Public Health Benefits of Nalmefene and Psychosocial Support for the Reduction of Alcohol Consumption in Alcohol Dependence

(2016) Philippe Laramée et al.   Applied Health Economics and Health Policy

The New French Guidelines on Alcohol Misuse: An Initiative for Strengthening Cross-European Interplay

(2015) Benjamin Rolland et al.   ADDICTION

Feeding Two Birds with One Scone: The Case of Varenicline

(2015) Henri-Jean Aubin et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Recommendations for the Design and Analysis of Treatment Trials for Alcohol Use Disorders

(2015) Katie Witkiewitz et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Varenicline for Treatment of Alcohol Dependence: A Randomized, Placebo-Controlled Trial

(2015) Andrea de Bejczy et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Guidelines for the Reporting of Treatment Trials for Alcohol Use Disorders

(2015) Katie Witkiewitz et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Women’s health in the Lund area (WHILA) - Alcohol consumption and all-cause mortality among women – a 17 year follow-up study

(2015) Patrik Midlöv et al.   BMC PUBLIC HEALTH

Pharmacotherapy for Alcohol Dependence: The 2015 Recommendations of the French Alcohol Society, Issued in Partnership with the European Federation of Addiction Societies

(2015) Benjamin Rolland et al.   CNS Neuroscience & Therapeutics

Leitlinienorientierte Behandlung alkoholbezogener Störungen

(2015) K. Mann et al.   NERVENARZT

Clinical Relevance of As-Needed Treatment with Nalmefene in Alcohol-Dependent Patients

(2015) Henri-Jean Aubin et al.   EUROPEAN ADDICTION RESEARCH

All cause mortality and the case for age specific alcohol consumption guidelines: pooled analyses of up to 10 population based cohorts

(2015) C. S. Knott et al.   BMJ-British Medical Journal

Harm Reduction as “Continuum Care” in Alcohol Abuse Disorder

(2015) Icro Maremmani et al.   International Journal of Environmental Research and Public Health

Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials

(2015) Clément Palpacuer et al.   PLOS MEDICINE

All cause mortality and the case for age specific alcohol consumption guidelines: pooled analyses of up to 10 population based cohorts

(2015) C. S. Knott et al.   BMJ-British Medical Journal

The Effects of as-Needed Nalmefene on Patient-Reported Outcomes and Quality of Life in Relation to a Reduction in Alcohol Consumption in Alcohol-Dependent Patients

(2015) Clément François et al.   PLoS One

A Meta-Analysis of Topiramate's Effects for Individuals with Alcohol Use Disorders

(2014) Janet C. Blodgett et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Topiramate Treatment for Heavy Drinkers: Moderation by aGRIK1Polymorphism

(2014) Henry R. Kranzler et al.   AMERICAN JOURNAL OF PSYCHIATRY

Varenicline in the Treatment of Alcohol Use Disorders

(2014) Beth L. Erwin et al.   ANNALS OF PHARMACOTHERAPY

Alcohol consumption and symptoms as predictors for relapse of DSM-5 alcohol use disorder

(2014) Marlous Tuithof et al.   DRUG AND ALCOHOL DEPENDENCE

Current pharmacological treatment approaches for alcohol dependence

(2014) Christian A Müller et al.   EXPERT OPINION ON PHARMACOTHERAPY

Pharmacotherapy for Adults With Alcohol Use Disorders in Outpatient Settings

(2014) Daniel E. Jonas et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: A 1-year, randomised controlled study

(2014) Wim van den Brink et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Development of the Alcohol Quality of Life Scale (AQoLS): a new patient-reported outcome measure to assess health-related quality of life in alcohol use disorder

(2014) A. Luquiens et al.   QUALITY OF LIFE RESEARCH

Reduction of Drinking in Problem Drinkers and All-Cause Mortality

(2013) J. Rehm et al.   ALCOHOL AND ALCOHOLISM

The Declining Efficacy of Naltrexone Pharmacotherapy for Alcohol Use Disorders Over Time: A Multivariate Meta-Analysis

(2013) A. C. Del Re et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice

(2013) Henri-Jean Aubin et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Pharmacotherapy for alcohol dependence: status of current treatments

(2013) Johan Franck et al.   CURRENT OPINION IN NEUROBIOLOGY

Emerging pharmacotherapies for alcohol dependence: A systematic review focusing on reduction in consumption

(2013) Henri-Jean Aubin et al.   DRUG AND ALCOHOL DEPENDENCE

A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence

(2013) Antoni Gual et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

A Double-Blind, Placebo-Controlled Trial Assessing the Efficacy of Varenicline Tartrate for Alcohol Dependence

(2013) Raye Z. Litten et al.   Journal of Addiction Medicine

Reduced-risk drinking as a viable treatment goal in problematic alcohol use and alcohol dependence

(2013) Jan van Amsterdam et al.   JOURNAL OF PSYCHOPHARMACOLOGY

The cardioprotective association of average alcohol consumption and ischaemic heart disease: a systematic review and meta-analysis

(2012) Michael Roerecke et al.   ADDICTION

Extending the Treatment Options in Alcohol Dependence: A Randomized Controlled Study of As-Needed Nalmefene

(2012) Karl Mann et al.   BIOLOGICAL PSYCHIATRY

Quality of life among alcohol-dependent patients: How satisfactory are the available instruments? A systematic review

(2012) A. Luquiens et al.   DRUG AND ALCOHOL DEPENDENCE

Epidemiology and alcohol policy in Europe

(2011) Jürgen Rehm et al.   ADDICTION

It is time for low-risk drinking goals to come out of the closet

(2011) MARK B. SOBELL et al.   ADDICTION

The Efficacy of Disulfiram for the Treatment of Alcohol Use Disorder

(2011) Charlotte H. Jørgensen et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Racial and Ethnic Differences in All-Cause Mortality Risk According to Alcohol Consumption Patterns in the National Alcohol Surveys

(2011) W. C. Kerr et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

The relation between different dimensions of alcohol consumption and burden of disease: an overview

(2010) Jürgen Rehm et al.   ADDICTION

Initial Preference for Drinking Goal in the Treatment of Alcohol Problems: II. Treatment Outcomes

(2010) S. J. Adamson et al.   ALCOHOL AND ALCOHOLISM

Initial Preference for Drinking Goal in the Treatment of Alcohol Problems: I. Baseline Differences Between Abstinence and Non-Abstinence Groups

(2010) N. Heather et al.   ALCOHOL AND ALCOHOLISM

Update on Harm-Reduction Policy and Intervention Research

(2010) G. Alan Marlatt et al.   Annual Review of Clinical Psychology

Searching for Responders to Acamprosate and Naltrexone in Alcoholism Treatment: Rationale and Design of thePredict Study

(2009) Karl Mann et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Alcohol as a Risk Factor for Type 2 Diabetes: A systematic review and meta-analysis

(2009) D. O. Baliunas et al.   DIABETES CARE

Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders

(2009) Jürgen Rehm et al.   LANCET

Transitions In and Out of Alcohol Use Disorders: Their Associations with Conditional Changes in Quality of Life Over a 3-Year Follow-Up Interval

(2008) D. A. Dawson et al.   ALCOHOL AND ALCOHOLISM

Effect of Extended-Release Naltrexone (XR-NTX) on Quality of Life in Alcohol-Dependent Patients

(2008) Helen M. Pettinati et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Update on neuropharmacological treatments for alcoholism: Scientific basis and clinical findings

(2007) Bankole A. Johnson   BIOCHEMICAL PHARMACOLOGY